Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $43.65 million versus the consensus estimate of $43.89 million.

GUIDANCE:

Evolus sees FY2023 revenue of $180-190 million, versus the consensus of $187.1 million.

For earnings history and earnings-related data on Evolus (EOLS) click here.